Adage Capital Partners Gp, L.L.C. Biomarin Pharmaceutical Inc Transaction History

Adage Capital Partners Gp, L.L.C.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $5.67 Million - $7.6 Million	70,000 Added 8.24%	920,000 $95.2 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $43.1 Million - $50.9 Million	-525,000 Reduced 38.18%	850,000 $72.1 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $7.15 Million - $8.69 Million	-100,000 Reduced 6.78%	1,375,000 $114 Million
Q1 2022 May 16, 2022	SELL	$74.28 - $92.69 $29 Million - $36.1 Million	-390,000 Reduced 20.91%	1,475,000 $114 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $105 Million - $135 Million	1,470,498 Added 372.75%	1,865,000 $165 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $29.5 Million - $33.7 Million	394,502 New	394,502 $30.5 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $35.1 Million - $43.7 Million	-484,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $29.5 Million - $53.7 Million	-410,000 Reduced 45.86%	484,000 $36.8 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $44.5 Million - $69.5 Million	559,124 Added 166.96%	894,000 $110 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $23.9 Million - $32.4 Million	334,876 New	334,876 $28.3 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $6.75 Million - $7.89 Million	-84,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $7.07 Million - $8.28 Million	84,000 New	84,000 $7.46 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.